Warwick J. Britton - Search Results

Year	Number of Results
2001	1
2002	7
2003	7
2004	7
2005	6
2006	8
2007	6
2008	3
2009	5
2010	7
2011	7
2012	10
2013	10
2014	8
2015	5
2016	11
2017	8
2018	16
2019	12
2020	9
2021	24
2022	26
2023	8
2024	2

1

Understanding the pathogenesis of occupational coal and silica dust-associated lung disease.

Vanka KS, Shukla S, Gomez HM, James C, Palanisami T, Williams K, Chambers DC, Britton WJ, Ilic D, Hansbro PM, Horvat JC. Vanka KS, et al. Among authors: britton wj. Eur Respir Rev. 2022 Jul 12;31(165):210250. doi: 10.1183/16000617.0250-2021. Print 2022 Sep 30. Eur Respir Rev. 2022. PMID: 35831008 Free PMC article. Review.

2

Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis.

Sawyer AJ, Patrick E, Edwards J, Wilmott JS, Fielder T, Yang Q, Barber DL, Ernst JD, Britton WJ, Palendira U, Chen X, Feng CG. Sawyer AJ, et al. Among authors: britton wj. J Exp Med. 2023 Jun 5;220(6):e20221392. doi: 10.1084/jem.20221392. Epub 2023 Mar 15. J Exp Med. 2023. PMID: 36920308 Free PMC article.

3

Leprosy.

Britton WJ, Lockwood DN. Britton WJ, et al. Lancet. 2004 Apr 10;363(9416):1209-19. doi: 10.1016/S0140-6736(04)15952-7. Lancet. 2004. PMID: 15081655 Review.

4

Total Synthesis of Ecumicin.

Hawkins PME, Giltrap AM, Nagalingam G, Britton WJ, Payne RJ. Hawkins PME, et al. Among authors: britton wj. Org Lett. 2018 Feb 16;20(4):1019-1022. doi: 10.1021/acs.orglett.7b03967. Epub 2018 Feb 7. Org Lett. 2018. PMID: 29412668

5

Deciphering protective immunity against tuberculosis: implications for vaccine development.

Counoupas C, Triccas JA, Britton WJ. Counoupas C, et al. Among authors: britton wj. Expert Rev Vaccines. 2019 Apr;18(4):353-364. doi: 10.1080/14760584.2019.1585246. Epub 2019 Mar 4. Expert Rev Vaccines. 2019. PMID: 30793629 Review.

6

Advances in the development of antimicrobial peptides and proteins for inhaled therapy.

Wang Y, Chang RYK, Britton WJ, Chan HK. Wang Y, et al. Among authors: britton wj. Adv Drug Deliv Rev. 2022 Jan;180:114066. doi: 10.1016/j.addr.2021.114066. Epub 2021 Nov 20. Adv Drug Deliv Rev. 2022. PMID: 34813794 Review.

7

Learning from the genetics of enteric tuberculosis.

Fox GJ, Britton WJ. Fox GJ, et al. Among authors: britton wj. J Gastroenterol Hepatol. 2011 Jul;26(7):1086-8. doi: 10.1111/j.1440-1746.2011.06763.x. J Gastroenterol Hepatol. 2011. PMID: 21672018 No abstract available.

8

No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis.

Quan DH, Kwong AJ, Hansbro PM, Britton WJ. Quan DH, et al. Among authors: britton wj. Eur Respir Rev. 2022 Jun 7;31(164):210252. doi: 10.1183/16000617.0252-2021. Print 2022 Jun 30. Eur Respir Rev. 2022. PMID: 35675921 Free PMC article. Review.

9

Dry powder inhalable formulations for anti-tubercular therapy.

Parumasivam T, Chang RY, Abdelghany S, Ye TT, Britton WJ, Chan HK. Parumasivam T, et al. Adv Drug Deliv Rev. 2016 Jul 1;102:83-101. doi: 10.1016/j.addr.2016.05.011. Epub 2016 May 17. Adv Drug Deliv Rev. 2016. PMID: 27212477 Review.

10

Total Synthesis of Teixobactin.

Giltrap AM, Dowman LJ, Nagalingam G, Ochoa JL, Linington RG, Britton WJ, Payne RJ. Giltrap AM, et al. Among authors: britton wj. Org Lett. 2016 Jun 3;18(11):2788-91. doi: 10.1021/acs.orglett.6b01324. Epub 2016 May 18. Org Lett. 2016. PMID: 27191730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

189 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year